Method for diagnosing neoplasia by detecting expression of PRAD1 cyclin
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 12, 1999
Issued Date -
N/A
app pub date -
Jun 2, 1995
filing date -
Mar 11, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A novel cyclin, termed prad1, is disclosed, along with the nucleic acid sequence that encodes human prad1. Antibodies that bind specifically to prad1 and cell lines and transgenic animals containing DNA that encodes prad1 are also disclosed. In addition, methods of using the antibodies or fragments of the nucleic acid sequence, for example, to diagnose a neoplastic condition by detecting expression of prad1 or to modulate cellular proliferation, are disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully